Fig. 1From: Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a reviewEstimated median prevalence of NPAEs with anti-malarial prophylaxis (P), treatment (T) or combined prophylaxis and treatment (C) [5]Back to article page